BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27852955)

  • 1. Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.
    Muhlebach MS; Beckett V; Popowitch E; Miller MB; Baines A; Mayer-Hamblett N; Zemanick ET; Hoover WC; VanDalfsen JM; Campbell P; Goss CH;
    Thorax; 2017 Apr; 72(4):318-326. PubMed ID: 27852955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009650. PubMed ID: 30030966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD009650. PubMed ID: 36511181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis--the PMEP trial: study protocol for a randomized controlled trial.
    Jennings MT; Boyle MP; Weaver D; Callahan KA; Dasenbrook EC
    Trials; 2014 Jun; 15():223. PubMed ID: 24925006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme.
    Kiefer A; Bogdan C; Melichar VO
    BMC Pulm Med; 2018 Jan; 18(1):20. PubMed ID: 29370836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of a methicillin-resistant Staphylococcus aureus (MRSA) eradication protocol in pediatric cystic fibrosis (CF) patients.
    Belarski E; Pettit R
    Pediatr Pulmonol; 2020 Mar; 55(3):654-659. PubMed ID: 31899860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study.
    Dolce D; Neri S; Grisotto L; Campana S; Ravenni N; Miselli F; Camera E; Zavataro L; Braggion C; Fiscarelli EV; Lucidi V; Cariani L; Girelli D; Faelli N; Colombo C; Lucanto C; Lombardo M; Magazzù G; Tosco A; Raia V; Manara S; Pasolli E; Armanini F; Segata N; Biggeri A; Taccetti G
    PLoS One; 2019; 14(3):e0213497. PubMed ID: 30901344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers.
    Huang SS; Singh R; McKinnell JA; Park S; Gombosev A; Eells SJ; Gillen DL; Kim D; Rashid S; Macias-Gil R; Bolaris MA; Tjoa T; Cao C; Hong SS; Lequieu J; Cui E; Chang J; He J; Evans K; Peterson E; Simpson G; Robinson P; Choi C; Bailey CC; Leo JD; Amin A; Goldmann D; Jernigan JA; Platt R; Septimus E; Weinstein RA; Hayden MK; Miller LG;
    N Engl J Med; 2019 Feb; 380(7):638-650. PubMed ID: 30763195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients.
    Vanderhelst E; De Wachter E; Willekens J; Piérard D; Vincken W; Malfroot A
    J Cyst Fibros; 2013 Dec; 12(6):662-6. PubMed ID: 23706641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical Trial.
    Huang SS; Septimus EJ; Kleinman K; Heim LT; Moody JA; Avery TR; McLean L; Rashid S; Haffenreffer K; Shimelman L; Staub-Juergens W; Spencer-Smith C; Sljivo S; Rosen E; Poland RE; Coady MH; Lee CH; Blanchard EJ; Reddish K; Hayden MK; Weinstein RA; Carver B; Smith K; Hickok J; Lolans K; Khan N; Sturdevant SG; Reddy SC; Jernigan JA; Sands KE; Perlin JB; Platt R
    JAMA; 2023 Oct; 330(14):1337-1347. PubMed ID: 37815567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
    Champion EA; Miller MB; Popowitch EB; Hobbs MM; Saiman L; Muhlebach MS;
    Pediatr Pulmonol; 2014 Mar; 49(3):230-7. PubMed ID: 23765686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
    Dezube R; Jennings MT; Rykiel M; Diener-West M; Boyle MP; Chmiel JF; Dasenbrook EC
    J Cyst Fibros; 2019 May; 18(3):357-363. PubMed ID: 30131297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Hurley MN; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009650. PubMed ID: 23450608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk.
    Robicsek A; Beaumont JL; Thomson RB; Govindarajan G; Peterson LR
    Infect Control Hosp Epidemiol; 2009 Jul; 30(7):623-32. PubMed ID: 19496730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Total Household Decolonization on Clearance of Colonization With Methicillin-Resistant Staphylococcus aureus.
    Cluzet VC; Gerber JS; Metlay JP; Nachamkin I; Zaoutis TE; Davis MF; Julian KG; Linkin DR; Coffin SE; Margolis DJ; Hollander JE; Bilker WB; Han X; Mistry RD; Gavin LJ; Tolomeo P; Wise JA; Wheeler MK; Hu B; Fishman NO; Royer D; Lautenbach E;
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1226-33. PubMed ID: 27465112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intubated patients.
    Camus C; Sebille V; Legras A; Garo B; Renault A; Le Corre P; Donnio PY; Gacouin A; Perrotin D; Le Tulzo Y; Bellissant E
    Infection; 2014 Jun; 42(3):493-502. PubMed ID: 24464791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and treatment of methicillin-resistant S. aureus infection in cystic fibrosis patients: a cohort study.
    Bittencourt PH; Pimentel CS; Bonfim BS; Marostica PJ; Souza EL
    Braz J Infect Dis; 2017; 21(1):107-111. PubMed ID: 27755979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of methicillin resistant Staphylococcus aureus detected for the first time in cystic fibrosis: A single center observational study.
    Kappler M; Nagel F; Feilcke M; Kröner C; Pawlita I; Naehrig S; Ripper J; Hengst M; von Both U; Forstner M; Hector A; Griese M
    Pediatr Pulmonol; 2016 Oct; 51(10):1010-1019. PubMed ID: 27378061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
    Tong SY; Nelson J; Paterson DL; Fowler VG; Howden BP; Cheng AC; Chatfield M; Lipman J; Van Hal S; O'Sullivan M; Robinson JO; Yahav D; Lye D; Davis JS;
    Trials; 2016 Mar; 17():170. PubMed ID: 27029920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection.
    Harbarth S; von Dach E; Pagani L; Macedo-Vinas M; Huttner B; Olearo F; Emonet S; Uçkay I
    J Antimicrob Chemother; 2015 Jan; 70(1):264-72. PubMed ID: 25209610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.